3Davis W D, Brey R L. Complement activation in stoke associated with antiphospholipid antibodies[ J] Neurology, 1994,41 ( 3 ) :296 - 298.
4Vaarala O, Manttari M, Manninen V, et al. Anti - carcliolipin antibodies and risk of myocardial infarction in a prospective cohort of middle - aged men [J ]. Circulation,1995,91(1) :23 - 27.
5Douglas A, Triplett. Antiphospbolipid - protein antibodies: Laboratory detection and clinical relevance [ J ]. Thromb Res, 1995,78(1) : 1 - 31.
6Meroni PL, Papa ND, Beltrami B, et al. Modulation of endothelial cell function by antiphospholipid antibodies [ J ].Lupus, 1996; 5(5) : 448 - 450.
7Feinbrg WM, Bruck DE, Ring MI, et al. Hemastafic markers in acute stroke.Stroke, 1984, 20: 592.
8P.H. Lalive, MD; P.de Moerlcose, MD; KLovblad, et al.Is measurement of D - dimer useful in the diagnosis of cerebral venous txealment?Neurology, 2003, 61 : 1057 - 1059.
9Toshihiro Ueda, Takao Hatakeyama, Yoshiaki Kumen, et al. Evaluation of risk of hemorrhagic transformation in local intra - arterial thrombolysis in acute ischemic stroke by initial SPECT.Stroke, 1994, 25 (2): 298-302.
10H ideo T, Masahiro K, Kenichi T, et al.Coagulation - fibrinolysis al:mor-malities in acute and chronic phases of cerebral thrombosis and embolism.Stroke, 1990, 21: 1663.
